C12Y 101/01042
Isocitrate dehydrogenase
Official title: Isocitrate dehydrogenase (NADP+) (1.1.1.42)
C12Y101/01042 (Isocitrate dehydrogenase) appears on 20 US grants and 51 published applications in this corpus.
Search patents in C12Y- Granted patents
- 20
- Published applications
- 51
- Assignees
- 42
- Inventors
- 131
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 3 |
| 2015 | 0 | 2 |
| 2016 | 2 | 2 |
| 2017 | 0 | 4 |
| 2018 | 1 | 2 |
| 2019 | 1 | 3 |
| 2020 | 6 | 6 |
| 2021 | 2 | 4 |
| 2022 | 1 | 3 |
| 2023 | 1 | 10 |
| 2024 | 4 | 4 |
| 2025 | 2 | 3 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biosynthetic production of gamma- and delta-lactones using cytochrome P450 enzymes having subterminal hydroxylase activity16 Sep 2025US 12,416,028 B2Conagen Inc.
- Delivery of gene therapy treatments26 Aug 2025US 12,397,066 B2Indiana University Research and Technology Corporation
- Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof3 Sep 2024US 12,077,785 B2Sotio Biotech Inc.
- Methods of use for an NADPH-regeneration system based on a monomeric isocitrate dehydrogenase18 Jun 2024US 12,012,619 B2Industry Foundation of Chonnam National University
- Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods27 Feb 2024US 11,911,487 B2Indiana University Research and Technology Corporation
- Anti-cancer treatments and methods of use thereof8 Oct 2026US 2026/0308535 A1
- Anaerobic co-production of essential amino acids, alcohols and lipids from molasses, hydrolysed starch and lignocellulose10 Sep 2026US 2026/0265796 A1SNL BioSolution Aps
- Modulation of nadph generation by recombinant yeast host cell during fermentation28 May 2026US 2026/0146255 A1Danstar Ferment AG
- Methods to treat acute kidney injury with a fluid25 Dec 2025US 2025/0387520 A1Indiana University Research and Technology Corporation
- Methods and compositions for cell-proliferation-related disorders11 Dec 2025US 2025/0378926 A1Servier Pharmaceuticals LLC
Most cited
By later US patents
- Methods and compositions for cell-proliferation-related disorders9US 10,610,125 B2Agios Pharmaceuticals, Inc. · 2020
- Multi-substrate metabolism for improving biomass and lipid production3US 11,220,675 B2Provivi, Inc. · 2022
- Use of Methylomonas sp. DH-1 strain and its transformants2US 10,858,661 B2University-Industry Cooperation Group of Kyung Hee University · 2020
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 10,576,124 B2Stealth BioTherapeutics Inc. · 2020
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 11,141,456 B2Stealth BioTherapeutics Inc. · 2021